ArticleScientific reports2026
Age-grading and species identification of male mosquito Anopheles gambiae s.l. using mid-infrared spectroscopy and machine learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Most malaria vector control strategies target female Anopheles mosquitoes that transmit parasites, but emerging approaches such as gene drive, sterile insect technique, or Wolbachia require the release of males. Successful deployment depends on reliable knowledge of the species composition and age structure of male populations to overcome potential barriers to mating. Although approaches including near-infrared spectroscopy have been explored for male species identification and age grading, these methods remain constrained by limited validation, scalability, and accuracy under operational field conditions. Here we tested mid-infrared spectroscopy (MIRS) coupled with machine learning (ML) as a rapid and cost-effective approach for classifying species and age of male mosquitoes within the Anopheles gambiae complex. We used male mosquitoes from two laboratory-reared colonies in Burkina Faso (Anopheles coluzzii and An. gambiae) to develop a MIRS-ML model for species and age group (1–4, 5–10, 11–17 days) prediction under controlled conditions. This model was tested against a genetic and environmentally variable dataset consisting of male offspring obtained from gravid or blood fed Anopheles coluzzii and An. gambiae females collected from houses from two villages, Vallée du Kou and Soumousso and reared to adulthood in a semi-field system. The MIRS spectra from 2,120 males, representing both species, all age groups and both laboratory and semi-field backgrounds, were analysed using an extreme gradient boosting (XGBoost) algorithm to assess the ability to correctly predict age group and species. The XGBoost model classified mosquito species (86%) and age groups (85%) accurately in laboratory data, but performance declined under semi-field conditions (64% for species, 50% for age), reflecting environmental variability. Incorporating semi-field samples through transfer learning improved accuracy to 73% for species and 70% for age, underscoring both the limits of laboratory-only models and the value of transfer learning for enhancing generalisability in field settings. Our results demonstrate that mid-infrared spectroscopy with supervised machine learning (MIRS-ML) holds potential as a rapid tool for identifying the species and age group of cryptic male malaria vectors and represent one of the first applications of this approach to male Anopheles gambiae s.l. evaluated under semi-field conditions. However, before the approach can be used, larger datasets are needed to improve the classification algorithms and validate them for prediction in field populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.